Stay updated with breaking news from Oche. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The small molecule drug alectinib (Alecensa) developed by the big pharma company Roche has improved disease-free survival in patients with a specific form of non-small cell lung cancer (NSCLC) when delivered as an adjuvant therapy in a phase 3 trial.
Soobben says his drawings have angered some politicians who are not willing to help him keep the school in SA
Setyembre 3, 2023 - Linggo Metro Manila Turf Club - Tanauan City, Batangas.
StockNews.com upgraded shares of Chemed (NYSE:CHE – Free Report) from a hold rating to a buy rating in a research note published on Wednesday morning. Separately, Royal Bank of Canada decreased their price objective on shares of Chemed from $610.00 to $576.00 and set an outperform rating for the company in a research report on […]
UK's NHS introduces groundbreaking cancer treatment injection, potentially reducing treatment times for eligible patients by three quarters